{"gene":"PAM","run_date":"2026-06-10T05:19:53","timeline":{"discoveries":[{"year":2015,"finding":"PAM (peptidylglycine α-amidating monooxygenase) catalyzes C-terminal amidation of peptidylglycine substrates in two sequential steps: the PHM (peptidylglycine α-hydroxylating monooxygenase) domain catalyzes copper- and ascorbate-dependent α-hydroxylation, and the PAL (peptidyl-α-hydroxyglycine α-amidating lyase) domain cleaves the N-C bond to produce amidated peptide and glyoxylate. Both catalytic cores are contained within the luminal domain of PAM, a type 1 integral membrane protein, and crystal structures of both catalytic cores have been determined revealing interactions with metals, molecular oxygen, and substrate.","method":"Biochemical purification, enzymatic assay, structural determination (crystallography), cloning","journal":"Journal of molecular endocrinology","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structures of both catalytic cores determined, in vitro enzymatic assays, replicated across multiple labs over decades","pmids":["26667899"],"is_preprint":false},{"year":2000,"finding":"In Drosophila, PHM (the ortholog of human PAM's PHM domain) is the rate-limiting enzyme for C-terminal α-amidation of secretory peptides. PHM null mutants lack PHM protein and enzyme activity, die as late embryos or young larvae, and show near-complete absence of amidated peptides while peptide precursors, non-amidated neuropeptides, and other biosynthetic enzymes remain detectable. PHM is required throughout the life of Drosophila for peptide amidating activity.","method":"Genetic loss-of-function (null mutants, hypomorphs), transgenic rescue, enzymatic activity assay, immunodetection of neuropeptides","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple alleles, rescue experiments, direct biochemical validation of enzyme activity loss and substrate accumulation","pmids":["10993678"],"is_preprint":false},{"year":1994,"finding":"PAM-1, a type I integral membrane protein, was purified to homogeneity from stably transfected HEK-293 cell membranes. Purified PAM-1 exhibits an acidic pH optimum and lower maximal velocity than soluble bifunctional PAM. Limited tryptic digestion of PAM-1 releases monofunctional PHM (peptidylglycine α-hydroxylating monooxygenase), increasing its specific activity ~fourfold and shifting its pH optimum to match that of PAL (peptidyl-α-hydroxyglycine α-amidating lyase).","method":"Affinity chromatography purification, enzymatic activity assay (in vitro), limited proteolysis","journal":"Archives of biochemistry and biophysics","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro biochemical reconstitution with purified protein and defined enzymatic assays in a single rigorous study","pmids":["8037462"],"is_preprint":false},{"year":2010,"finding":"PAM (also called Myc-bp2/MYCBP2) and Arf-bp1 are E3 ubiquitin ligases that co-purify with the circadian heme receptor Rev-erb alpha and are required for its ubiquitination. RNA interference-mediated depletion of Arf-bp1 and Pam stabilizes Rev-erb alpha protein and protects it from degradation triggered by lithium or serum shock, thereby modulating Clock gene expression and circadian function in mouse hepatoma cells.","method":"Co-purification (biochemical), RNA interference (RNAi) knockdown, ubiquitination assay, protein stability assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal co-purification plus functional RNAi with defined molecular phenotype (ubiquitination and protein stability), two orthogonal methods","pmids":["20534529"],"is_preprint":false},{"year":2003,"finding":"Pam (Protein associated with Myc/MYCBP2) physically associates with the tuberin-hamartin (TSC2-TSC1) complex in the brain. The C-terminal RING zinc finger domain of Pam binds to tuberin. Pam co-localizes with tuberin and hamartin in neurites and growth cones of cortical neurons. Genetic studies in Drosophila showed that Highwire (the Pam ortholog) can genetically interact with the Tsc1·Tsc2 complex and negatively regulate its activity.","method":"Co-immunoprecipitation, yeast two-hybrid, co-localization (immunofluorescence), Drosophila genetic epistasis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP and domain mapping plus genetic epistasis in Drosophila, but mechanistic detail on ubiquitination not yet shown in this paper","pmids":["14559897"],"is_preprint":false},{"year":2008,"finding":"Pam (MYCBP2) functions as an E3 ubiquitin ligase: it associates with E2 ubiquitin-conjugating enzymes and ubiquitinates tuberin (TSC2) through its RING finger domain in mammalian cells. Tuberin ubiquitination by Pam is independent of its phosphorylation by Akt, RSK1, or ERK. Pam also self-ubiquitinates via its RING finger domain. The TSC1 protein hamartin protects tuberin from Pam-mediated ubiquitination, but fails to protect a disease-associated TSC2 missense mutant. Pam knockdown by RNAi in rat primary neurons elevates tuberin levels and inhibits mTOR signaling.","method":"In vitro ubiquitination assay, co-immunoprecipitation, RNAi knockdown, mTOR pathway readout, domain mutagenesis (RING finger)","journal":"Cellular signalling","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro ubiquitination assay with domain mutagenesis, RNAi with defined pathway phenotype, and Co-IP; multiple orthogonal methods in one study","pmids":["18308511"],"is_preprint":false},{"year":2018,"finding":"Human PAM (MYCBP2) forms a noncanonical SCF-like ubiquitin ligase complex containing FBXO45 and SKP1 but lacking CUL1. FBXO45 is important for assembly of the PAM/FBXO45/SKP1 complex rather than solely for substrate recognition. SKP1 acts as an auxiliary component of the target recognition module, enhancing FBXO45 binding to NMNAT2. PAM polyubiquitinates NMNAT2 and regulates NMNAT2 protein stability and degradation by the proteasome.","method":"Co-immunoprecipitation, biochemical reconstitution of complex, in vitro ubiquitination assay, proteasome degradation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — biochemical reconstitution of SCF-like complex, in vitro ubiquitination assay, protein stability assay; multiple orthogonal methods","pmids":["29997255"],"is_preprint":false},{"year":2004,"finding":"PAM (Protein Associated with Myc/MYCBP2) is one of the most potent inhibitors of adenylyl cyclase activity. PAM localizes at the endoplasmic reticulum in HeLa cells and is recruited to the plasma membrane upon treatment with sphingosine-1-phosphate (S1P), causing inhibition of adenylyl cyclase activity. S1P-induced late-phase adenylyl cyclase inhibition (20–240 min) is PAM-dependent, whereas the initial phase (1–10 min) is Gi-mediated and PAM-independent. This makes PAM the longest-lasting nontranscriptional regulator of adenylyl cyclase activity known.","method":"Subcellular fractionation/localization, purification of S1P as serum factor, adenylyl cyclase activity assay, PAM knockdown","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct localization with functional consequence, biochemical activity assay, identification of upstream activating signal, and functional knockdown; multiple orthogonal methods","pmids":["15257286"],"is_preprint":false},{"year":2010,"finding":"The cytosolic domain (CD) of PAM (peptidylglycine α-amidating monooxygenase) is basally phosphorylated by Uhmk1 (U2AF homology motif kinase 1) and other Ser/Thr kinases. Endoproteolytic cleavage of PAM releases a soluble CD fragment that localizes to the nucleus. Nuclear localization of PAM-CD is decreased by phosphomimetic mutations in PAM-CD or by overexpression of active Uhmk1. PAM-CD can increase expression of a subset of genes including aquaporin 1 (Aqp1) in AtT-20 cells, and this relationship was confirmed in vivo in Pam heterozygous mice.","method":"Kinase assay (phosphorylation), subcellular fractionation/localization, microarray gene expression, transgenic mouse (Pam+/- vs Pam+/+), phosphomimetic mutagenesis","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (kinase assay, localization, mutagenesis, microarray, in vivo mouse model) establishing a secretory granule-to-nucleus signaling pathway","pmids":["20573687"],"is_preprint":false},{"year":2007,"finding":"The basic helix-loop-helix protein DIMMED (DIMM) directly activates transcription of the PHM gene (Drosophila ortholog of human PAM) in peptidergic neurons. DIMM activity requires its basic region and three E-box sites within PHM's first intron. All three E-boxes contribute to transcriptional activation and interact cooperatively. The mammalian DIMM ortholog MIST1 also transactivates the PHM gene. In vivo PHM regulatory region expression requires dimm function.","method":"Transfection/reporter assay in HEK293 cells, site-directed mutagenesis of E-box sites, in vivo Drosophila genetics (dimm mutants), ChIP-equivalent reporter analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — direct transcription factor binding and mutagenesis of target sites combined with in vivo genetic validation","pmids":["17967878"],"is_preprint":false},{"year":2008,"finding":"The RCC1 (Regulator of Chromatin Condensation) domain of PAM (Protein Associated with Myc) binds to the carboxyl terminus of the neuronal KCC2 potassium-chloride cotransporter. This interaction was identified by yeast two-hybrid, confirmed by GST pull-down, and co-immunoprecipitation after co-expression in HEK293 cells. Functional 86Rb/K+ uptake assays showed that RCC1/PAM causes increased KCC2-mediated ion flux. A point mutation in the 20-amino-acid KCC2 binding region abolishes both the RCC1/PAM interaction and N-ethylmaleimide activation of KCC2.","method":"Yeast two-hybrid, GST pull-down, co-immunoprecipitation, ion flux assay (86Rb uptake), site-directed mutagenesis","journal":"Cellular physiology and biochemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal binding assays (Y2H, GST pulldown, Co-IP) plus functional ion flux assay and domain mutagenesis linking interaction to function","pmids":["18769030"],"is_preprint":false},{"year":2021,"finding":"PAM (peptidylglycine α-amidating monooxygenase) is essential; mice lacking PAM survive only until mid-gestation. PAM is present in cilia of Chlamydomonas reinhardtii (a unicellular eukaryote lacking secretory granules), suggesting PAM-like enzyme was present in the last eukaryotic common ancestor. Despite similar catalytic features between human and C. reinhardtii PAM, trafficking of PAM differs between species. The intrinsically disordered cytosolic domain of PAM is not essential for catalytic activity but is essential for PAM trafficking.","method":"Genetic knockout (mouse), phylogenetic analysis, biochemical characterization, cell biological localization studies","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — review synthesizing multiple prior experiments including mouse knockout lethality and localization studies; no single new experiment but synthesizes established mechanistic findings","pmids":["34089560"],"is_preprint":false},{"year":2023,"finding":"Germline loss-of-function variants in the PAM gene (encoding peptidylglycine α-amidating monooxygenase) are enriched in subjects with pituitary hypersecretion. Functional testing of identified PAM variants in vitro demonstrated deleterious effects on protein expression, protein trafficking (Western blotting), mRNA splicing (minigene assays), and amidation activity (cell lysate and serum amidation assays), confirming that reduced PAM function is associated with pituitary adenoma and hypersecretion.","method":"Germline sequencing, Western blotting, minigene splicing assay, enzymatic amidation activity assay in cell lysates and serum","journal":"Frontiers in endocrinology","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — functional in vitro validation of multiple variants by distinct methods (expression, trafficking, splicing, enzymatic activity), single lab","pmids":["37388215"],"is_preprint":false},{"year":2002,"finding":"PAM (Protein Associated with Myc/MYCBP2) mRNA is highly expressed in specific brain regions including hippocampus, dentate gyrus, and cerebellum, restricted to pyramidal cells of hippocampus and granule cells of dentate gyrus and cerebellum. PAM mRNA expression is developmentally regulated: it is turned on after birth and upregulated during the first postnatal two weeks, then remains elevated into adulthood. No alterations in PAM mRNA expression are detected in mice deficient in adenylyl cyclase isoforms I or VIII.","method":"In situ hybridization, developmental time course analysis, adenylyl cyclase knockout mouse analysis","journal":"Brain research. Developmental brain research","confidence":"Low","confidence_rationale":"Tier 3 / Weak — localization by in situ hybridization without direct functional consequence established; negative result regarding adenylyl cyclase isoform regulation","pmids":["12036515"],"is_preprint":false},{"year":1985,"finding":"The human precursor gene for VIP and PHM-27 was characterized: PHM-27 (the human ortholog of PHI, with N-terminal histidine and C-terminal methionine amide) and VIP are encoded on two separate, adjacent exons separated by a 0.75-kb intron. Each exon encodes both the hormone amino acid residues and post-translational processing signal sequences. The 3' splice sites of the two exons contain an identical stretch of nine nucleotides, suggesting possible alternative RNA processing.","method":"Oligodeoxynucleotide probe hybridization, direct DNA sequencing, gene structure analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct sequencing establishing gene structure with distinct exons for PHM-27 and VIP; foundational structural finding","pmids":["2987932"],"is_preprint":false},{"year":1988,"finding":"The complete human VIP/PHM-27 gene spans 8,837 bp and consists of seven exons and six introns. PHM-27 is encoded by exon IV and VIP by exon V. The VIP- and PHM-27-encoding exons are homologous, suggesting duplication from an ancestral exon. The functional promoter (28 bp upstream of the cap site) is inducible by cAMP and phorbol esters in human neuroblastoma cells.","method":"DNA sequencing, primer extension, exon mapping, mung bean nuclease mapping, promoter-reporter assay","journal":"Annals of the New York Academy of Sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — complete gene sequencing combined with functional promoter mapping by multiple methods","pmids":["2839091"],"is_preprint":false},{"year":2010,"finding":"In Schistosoma mansoni, a monofunctional PAL (SmPAL) enzyme was identified that has functionally similar catalytic activity to the PAL domain of human bifunctional PAM but shows key catalytic core amino acid substitutions. SmPAL mRNA is expressed in neuronal cell bodies of the central nervous system of adult schistosomes, consistent with its role in amidating neuropeptides for neuromuscular function.","method":"Heterologous expression and enzymatic characterization, in situ hybridization, RNAi (knockdown attempted with variable success)","journal":"Molecular and biochemical parasitology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — ortholog characterization in a parasitic organism; mechanistic findings indirect to human PAM; single lab, single main method for functional characterization","pmids":["20488212"],"is_preprint":false}],"current_model":"PAM (peptidylglycine α-amidating monooxygenase/MYCBP2) is a multifunctional type I integral membrane protein: its luminal domain contains two catalytic cores (PHM and PAL) that sequentially catalyze copper- and ascorbate-dependent C-terminal α-amidation of peptidylglycine substrates; its intrinsically disordered cytosolic domain, phosphorylated by Uhmk1, is essential for trafficking and mediates retrograde signaling from secretory granules to the nucleus to regulate gene expression; and separately, its RING finger-containing form (MYCBP2/PAM) functions as an E3 ubiquitin ligase within a noncanonical SCF complex (with FBXO45 and SKP1 but lacking CUL1) to ubiquitinate substrates including TSC2/tuberin and NMNAT2, thereby regulating mTOR signaling, axonal degeneration, and circadian rhythm (via Rev-erb alpha degradation), while its RCC1 domain interacts with and activates the KCC2 potassium-chloride cotransporter."},"narrative":{"mechanistic_narrative":"PAM is a multifunctional protein whose name reflects two distinct biochemical identities captured in this corpus. As peptidylglycine α-amidating monooxygenase, it is a type I integral membrane enzyme whose luminal domain houses two sequential catalytic cores—PHM, which performs copper- and ascorbate-dependent α-hydroxylation, and PAL, which cleaves the resulting peptidyl-α-hydroxyglycine to yield C-terminally amidated peptide and glyoxylate [PMID:26667899, PMID:8037462]. This bifunctional amidation is the rate-limiting step in producing mature bioactive secretory peptides, demonstrated by loss-of-function studies in Drosophila where PHM nulls fail to amidate neuropeptides and die during development [PMID:10993678]. The enzyme's intrinsically disordered cytosolic domain is dispensable for catalysis but essential for trafficking; it is phosphorylated by Uhmk1, and a cleaved soluble cytosolic fragment translocates to the nucleus to regulate expression of genes such as Aqp1, constituting a secretory-granule-to-nucleus signaling route [PMID:20573687, PMID:34089560]. PAM is essential in mouse (knockout lethal at mid-gestation), and germline loss-of-function variants that impair its expression, trafficking, splicing, and amidation activity are associated with pituitary hypersecretion and adenoma [PMID:34089560, PMID:37388215]. Separately, the same locus (also called MYCBP2/Pam) encodes a RING-finger E3 ubiquitin ligase that assembles a noncanonical SCF-like complex with FBXO45 and SKP1 but lacking CUL1; this complex polyubiquitinates substrates including TSC2/tuberin—thereby modulating mTOR signaling—and NMNAT2, controlling its proteasomal stability [PMID:18308511, PMID:29997255], and also targets the circadian receptor Rev-erbα for degradation to influence Clock gene expression [PMID:20534529]. Additional regulatory activities include potent, S1P-induced long-lasting inhibition of adenylyl cyclase [PMID:15257286] and an RCC1 domain that binds and activates the neuronal KCC2 potassium-chloride cotransporter [PMID:18769030].","teleology":[{"year":1985,"claim":"Establishing the genomic architecture of the amidated-peptide system showed that hormone-coding exons carry their own post-translational processing signals, framing amidation as a programmed maturation step.","evidence":"DNA sequencing and gene structure analysis of the human VIP/PHM-27 precursor gene","pmids":["2987932","2839091"],"confidence":"Medium","gaps":["Does not characterize the amidating enzyme itself","Promoter regulation studied only in neuroblastoma cells"]},{"year":1994,"claim":"Purification of the membrane enzyme to homogeneity defined PAM as a bifunctional type I integral membrane protein whose two catalytic activities can be physically separated, answering how a single protein performs two sequential reactions.","evidence":"Affinity purification from transfected HEK-293 membranes, in vitro enzymatic assays, limited proteolysis releasing monofunctional PHM","pmids":["8037462"],"confidence":"High","gaps":["Atomic-resolution catalytic mechanism not yet resolved","Physiological role of membrane vs soluble forms unclear"]},{"year":2000,"claim":"Genetic ablation in Drosophila established PHM/PAM as the rate-limiting and essential enzyme for peptide amidation in vivo, showing amidation is required for organismal viability.","evidence":"Null and hypomorph alleles, transgenic rescue, enzyme activity assay, neuropeptide immunodetection","pmids":["10993678"],"confidence":"High","gaps":["Specific amidated peptides essential for survival not pinpointed","Mammalian requirement not addressed here"]},{"year":2003,"claim":"Identification of PAM/MYCBP2 binding to the TSC1-TSC2 complex via its RING domain connected the locus to mTOR-pathway regulation and growth-cone biology.","evidence":"Co-IP, yeast two-hybrid, neuronal co-localization, Drosophila genetic epistasis with Tsc1/Tsc2","pmids":["14559897"],"confidence":"Medium","gaps":["Ubiquitination of tuberin not demonstrated in this study","Direct enzymatic activity inferred not shown"]},{"year":2004,"claim":"Discovery that PAM is an S1P-recruited, long-lasting inhibitor of adenylyl cyclase added a membrane-signaling function distinct from amidation.","evidence":"Subcellular localization, S1P identification as serum factor, adenylyl cyclase activity assay, PAM knockdown","pmids":["15257286"],"confidence":"High","gaps":["Molecular mechanism of cyclase inhibition unresolved","Which PAM form/domain mediates this is unclear"]},{"year":2008,"claim":"Demonstration that PAM functions as a bona fide RING E3 ligase that ubiquitinates tuberin and self-ubiquitinates, with TSC1 protection, defined its mechanism of mTOR regulation.","evidence":"In vitro ubiquitination with RING mutagenesis, Co-IP, neuronal RNAi with mTOR readout","pmids":["18308511"],"confidence":"High","gaps":["E2 partner identity not fully defined","Ubiquitin chain topology not characterized"]},{"year":2008,"claim":"Mapping the RCC1 domain interaction with KCC2 revealed a non-catalytic role in activating neuronal chloride transport.","evidence":"Yeast two-hybrid, GST pull-down, Co-IP, 86Rb ion flux assay, point mutagenesis of binding region","pmids":["18769030"],"confidence":"High","gaps":["Mechanism by which RCC1 binding activates transport unknown","In vivo relevance to neuronal chloride homeostasis untested here"]},{"year":2010,"claim":"Linking PAM/MYCBP2 to Rev-erbα ubiquitination extended its E3 ligase role into circadian regulation.","evidence":"Co-purification, RNAi stabilization of Rev-erbα, ubiquitination and protein stability assays in mouse hepatoma cells","pmids":["20534529"],"confidence":"High","gaps":["Direct vs indirect ubiquitination of Rev-erbα not fully separated from Arf-bp1 contribution","Complex composition for this substrate undefined"]},{"year":2010,"claim":"Identification of Uhmk1 phosphorylation of the cytosolic domain and nuclear translocation of a cleaved CD fragment established a secretory-granule-to-nucleus retrograde signaling pathway controlling gene expression.","evidence":"Kinase assay, subcellular fractionation, phosphomimetic mutagenesis, microarray, Pam+/- mouse validation","pmids":["20573687"],"confidence":"High","gaps":["Protease that generates the CD fragment not identified","Direct DNA/transcription-factor targets of CD unknown"]},{"year":2018,"claim":"Reconstitution of a noncanonical CUL1-lacking SCF-like complex (PAM/FBXO45/SKP1) targeting NMNAT2 defined the molecular architecture of PAM's ligase module and its role in NMNAT2 turnover.","evidence":"Co-IP, biochemical complex reconstitution, in vitro ubiquitination, proteasome degradation assay","pmids":["29997255"],"confidence":"High","gaps":["How substrate selection switches between TSC2, NMNAT2, and Rev-erbα is unresolved","Structural model of the assembled complex absent"]},{"year":2021,"claim":"Mouse knockout lethality plus conservation in a ciliated unicellular eukaryote established PAM as an ancient, essential enzyme and assigned the cytosolic domain a trafficking-specific, catalysis-independent role.","evidence":"Mouse knockout, phylogenetic analysis, Chlamydomonas localization, domain characterization (review synthesis)","pmids":["34089560"],"confidence":"Medium","gaps":["Species differences in trafficking mechanism unexplained","Cause of mid-gestation lethality not defined molecularly"]},{"year":2023,"claim":"Functional testing of germline loss-of-function variants tied reduced PAM amidation function to human pituitary hypersecretion and adenoma, providing a disease link.","evidence":"Germline sequencing with in vitro expression, trafficking, minigene splicing, and amidation activity assays","pmids":["37388215"],"confidence":"Medium","gaps":["Single-lab functional validation","Mechanism connecting reduced amidation to hypersecretion not established"]},{"year":null,"claim":"How the dual identities—amidating enzyme versus RING E3 ligase—relate at the level of gene products, and how the ligase selects among its diverse substrates, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of the substrate-recognition switch","Relationship between the amidation and ubiquitination functions of the locus unclear in the corpus"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[0,1,2]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0]},{"term_id":"GO:0016874","term_label":"ligase activity","supporting_discovery_ids":[5,6,3]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[5,6]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[8]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[7,10]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[2,7]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[7]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[8]},{"term_id":"GO:0005929","term_label":"cilium","supporting_discovery_ids":[11]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,1,2]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[5,7]},{"term_id":"R-HSA-9909396","term_label":"Circadian clock","supporting_discovery_ids":[3]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[8]}],"complexes":["noncanonical SCF-like complex (PAM/FBXO45/SKP1, lacking CUL1)"],"partners":["FBXO45","SKP1","TSC2","TSC1","NMNAT2","REV-ERBΑ","UHMK1","KCC2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P19021","full_name":"Peptidyl-glycine alpha-amidating monooxygenase","aliases":[],"length_aa":973,"mass_kda":108.3,"function":"Bifunctional enzyme that catalyzes amidation of the C-terminus of proteins (PubMed:12699694, PubMed:2357221). Alpha-amidation is present at the C-terminus of many endocrine hormones and neuropeptides and is required for their activity (PubMed:1575450). C-terminal amidation also takes place in response to protein fragmentation triggered by oxidative stress, promoting degradation of amidated protein fragments by the proteasome (PubMed:2207077). Alpha-amidation involves two sequential reactions, both of which are catalyzed by separate catalytic domains of the enzyme (PubMed:12699694). The first step, catalyzed by peptidyl alpha-hydroxylating monooxygenase (PHM) domain, is the copper-, ascorbate-, and O2- dependent stereospecific hydroxylation (with S stereochemistry) at the alpha-carbon (C-alpha) of the C-terminal glycine of the peptidylglycine substrate (PubMed:12699694). The second step, catalyzed by the peptidylglycine amidoglycolate lyase (PAL) domain, is the zinc-dependent cleavage of the N-C-alpha bond, producing the alpha-amidated peptide and glyoxylate (PubMed:12699694). Similarly, catalyzes the two-step conversion of an N-fatty acylglycine to a primary fatty acid amide and glyoxylate (By similarity)","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/P19021/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PAM","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PAM","total_profiled":1310},"omim":[{"mim_id":"621357","title":"CYSTEINE-RICH TAIL PROTEIN 1; CYSRT1","url":"https://www.omim.org/entry/621357"},{"mim_id":"619804","title":"DEAFNESS, AUTOSOMAL DOMINANT 82; DFNA82","url":"https://www.omim.org/entry/619804"},{"mim_id":"618535","title":"ECTODERMAL DYSPLASIA 15, HYPOHIDROTIC/HAIR TYPE; ECTD15","url":"https://www.omim.org/entry/618535"},{"mim_id":"617166","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 47; DEE47","url":"https://www.omim.org/entry/617166"},{"mim_id":"614041","title":"RB TRANSCRIPTIONAL COREPRESSOR 1; RB1","url":"https://www.omim.org/entry/614041"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Golgi apparatus","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"epididymis","ntpm":691.0},{"tissue":"heart muscle","ntpm":1159.0}],"url":"https://www.proteinatlas.org/search/PAM"},"hgnc":{"alias_symbol":["PAL","PHM","PAM-1"],"prev_symbol":[]},"alphafold":{"accession":"P19021","domains":[{"cath_id":"2.60.120.310","chopping":"50-194","consensus_level":"high","plddt":87.5937,"start":50,"end":194},{"cath_id":"2.60.120.230","chopping":"197-347","consensus_level":"high","plddt":92.3007,"start":197,"end":347},{"cath_id":"2.120.10.30","chopping":"502-811","consensus_level":"medium","plddt":91.6288,"start":502,"end":811}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P19021","model_url":"https://alphafold.ebi.ac.uk/files/AF-P19021-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P19021-F1-predicted_aligned_error_v6.png","plddt_mean":71.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PAM","jax_strain_url":"https://www.jax.org/strain/search?query=PAM"},"sequence":{"accession":"P19021","fasta_url":"https://rest.uniprot.org/uniprotkb/P19021.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P19021/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P19021"}},"corpus_meta":[{"pmid":"26098369","id":"PMC_26098369","title":"Engineered CRISPR-Cas9 nucleases with altered PAM specificities.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26098369","citation_count":1274,"is_preprint":false},{"pmid":"29512652","id":"PMC_29512652","title":"Evolved Cas9 variants with broad PAM compatibility and high DNA specificity.","date":"2018","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/29512652","citation_count":1168,"is_preprint":false},{"pmid":"25079318","id":"PMC_25079318","title":"Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease.","date":"2014","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/25079318","citation_count":989,"is_preprint":false},{"pmid":"28581492","id":"PMC_28581492","title":"Engineered Cpf1 variants with altered PAM specificities.","date":"2017","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/28581492","citation_count":327,"is_preprint":false},{"pmid":"27041224","id":"PMC_27041224","title":"Identifying and Visualizing Functional PAM Diversity across CRISPR-Cas Systems.","date":"2016","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/27041224","citation_count":251,"is_preprint":false},{"pmid":"32246713","id":"PMC_32246713","title":"PAM recognition by miniature CRISPR-Cas12f nucleases triggers programmable double-stranded DNA target cleavage.","date":"2020","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/32246713","citation_count":239,"is_preprint":false},{"pmid":"28781234","id":"PMC_28781234","title":"Structural Basis for the Canonical and Non-canonical PAM Recognition by CRISPR-Cpf1.","date":"2017","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/28781234","citation_count":213,"is_preprint":false},{"pmid":"33483498","id":"PMC_33483498","title":"CRISPR technologies and the search for the PAM-free nuclease.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33483498","citation_count":209,"is_preprint":false},{"pmid":"27984729","id":"PMC_27984729","title":"PAM-Dependent Target DNA Recognition and Cleavage by C2c1 CRISPR-Cas Endonuclease.","date":"2016","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/27984729","citation_count":208,"is_preprint":false},{"pmid":"30397647","id":"PMC_30397647","title":"Minimal PAM specificity of a highly similar SpCas9 ortholog.","date":"2018","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/30397647","citation_count":180,"is_preprint":false},{"pmid":"30109815","id":"PMC_30109815","title":"PAM identification by CRISPR-Cas effector complexes: diversified mechanisms and structures.","date":"2018","source":"RNA biology","url":"https://pubmed.ncbi.nlm.nih.gov/30109815","citation_count":179,"is_preprint":false},{"pmid":"33398158","id":"PMC_33398158","title":"PAM-less plant genome editing using a CRISPR-SpRY toolbox.","date":"2021","source":"Nature plants","url":"https://pubmed.ncbi.nlm.nih.gov/33398158","citation_count":170,"is_preprint":false},{"pmid":"27916599","id":"PMC_27916599","title":"Deciphering, Communicating, and Engineering the CRISPR PAM.","date":"2016","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/27916599","citation_count":126,"is_preprint":false},{"pmid":"26990991","id":"PMC_26990991","title":"Structural Basis for the Altered PAM Specificities of Engineered CRISPR-Cas9.","date":"2016","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/26990991","citation_count":118,"is_preprint":false},{"pmid":"2318966","id":"PMC_2318966","title":"Expression and modulation of nerve growth factor in murine keratinocytes (PAM 212).","date":"1990","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/2318966","citation_count":110,"is_preprint":false},{"pmid":"32393822","id":"PMC_32393822","title":"An engineered ScCas9 with broad PAM range and high specificity and activity.","date":"2020","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/32393822","citation_count":104,"is_preprint":false},{"pmid":"32424114","id":"PMC_32424114","title":"A Cas9 with PAM recognition for adenine dinucleotides.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/32424114","citation_count":92,"is_preprint":false},{"pmid":"30928636","id":"PMC_30928636","title":"Genome Engineering in Rice Using Cas9 Variants that Recognize NG PAM Sequences.","date":"2019","source":"Molecular plant","url":"https://pubmed.ncbi.nlm.nih.gov/30928636","citation_count":88,"is_preprint":false},{"pmid":"20534529","id":"PMC_20534529","title":"E3 ligases Arf-bp1 and Pam mediate lithium-stimulated degradation of the circadian heme receptor Rev-erb alpha.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20534529","citation_count":87,"is_preprint":false},{"pmid":"2987932","id":"PMC_2987932","title":"Coding sequences for vasoactive intestinal peptide and PHM-27 peptide are located on two adjacent exons in the human genome.","date":"1985","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2987932","citation_count":82,"is_preprint":false},{"pmid":"29883605","id":"PMC_29883605","title":"Cas4 Nucleases Define the PAM, Length, and Orientation of DNA Fragments Integrated at CRISPR Loci.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/29883605","citation_count":81,"is_preprint":false},{"pmid":"33636398","id":"PMC_33636398","title":"Engineered prime editors with PAM flexibility.","date":"2021","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33636398","citation_count":80,"is_preprint":false},{"pmid":"28595896","id":"PMC_28595896","title":"Structural Basis for the Altered PAM Recognition by Engineered CRISPR-Cpf1.","date":"2017","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/28595896","citation_count":78,"is_preprint":false},{"pmid":"10993678","id":"PMC_10993678","title":"PHM is required for normal developmental transitions and for biosynthesis of secretory peptides in Drosophila.","date":"2000","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10993678","citation_count":74,"is_preprint":false},{"pmid":"26667899","id":"PMC_26667899","title":"60 YEARS OF POMC: From POMC and α-MSH to PAM, molecular oxygen, copper, and vitamin C.","date":"2015","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/26667899","citation_count":71,"is_preprint":false},{"pmid":"14559897","id":"PMC_14559897","title":"Pam and its ortholog highwire interact with and may negatively regulate the TSC1.TSC2 complex.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14559897","citation_count":70,"is_preprint":false},{"pmid":"18308511","id":"PMC_18308511","title":"Pam (Protein associated with Myc) functions as an E3 ubiquitin ligase and regulates TSC/mTOR signaling.","date":"2008","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/18308511","citation_count":65,"is_preprint":false},{"pmid":"35308851","id":"PMC_35308851","title":"PAM-less conditional DNA substrates leverage trans-cleavage of CRISPR-Cas12a for versatile live-cell biosensing.","date":"2022","source":"Chemical science","url":"https://pubmed.ncbi.nlm.nih.gov/35308851","citation_count":61,"is_preprint":false},{"pmid":"3018707","id":"PMC_3018707","title":"The receptors of the VIP family peptides (VIP, secretin, GRF, PHI, PHM, GIP, glucagon and oxyntomodulin). Specificities and identity.","date":"1986","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/3018707","citation_count":60,"is_preprint":false},{"pmid":"34984801","id":"PMC_34984801","title":"PhieABEs: a PAM-less/free high-efficiency adenine base editor toolbox with wide target scope in plants.","date":"2022","source":"Plant biotechnology journal","url":"https://pubmed.ncbi.nlm.nih.gov/34984801","citation_count":57,"is_preprint":false},{"pmid":"29885909","id":"PMC_29885909","title":"PAM-Antagonists: A Better Way to Block Pathological Receptor Signaling?","date":"2018","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29885909","citation_count":55,"is_preprint":false},{"pmid":"32130891","id":"PMC_32130891","title":"High-Throughput Screens of PAM-Flexible Cas9 Variants for Gene Knockout and Transcriptional Modulation.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32130891","citation_count":54,"is_preprint":false},{"pmid":"37794046","id":"PMC_37794046","title":"PAM-flexible genome editing with an engineered chimeric Cas9.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37794046","citation_count":51,"is_preprint":false},{"pmid":"17967878","id":"PMC_17967878","title":"The Drosophila basic helix-loop-helix protein DIMMED directly activates PHM, a gene encoding a neuropeptide-amidating enzyme.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17967878","citation_count":48,"is_preprint":false},{"pmid":"15257286","id":"PMC_15257286","title":"PAM mediates sustained inhibition of cAMP signaling by sphingosine-1-phosphate.","date":"2004","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/15257286","citation_count":47,"is_preprint":false},{"pmid":"23392249","id":"PMC_23392249","title":"Genetic determinants of PAM-dependent DNA targeting and pre-crRNA processing in Sulfolobus islandicus.","date":"2013","source":"RNA biology","url":"https://pubmed.ncbi.nlm.nih.gov/23392249","citation_count":46,"is_preprint":false},{"pmid":"2422707","id":"PMC_2422707","title":"Effects of VIP, PHM and substance P on blood vessels and secretory elements of the human submandibular gland.","date":"1986","source":"Regulatory peptides","url":"https://pubmed.ncbi.nlm.nih.gov/2422707","citation_count":46,"is_preprint":false},{"pmid":"40262634","id":"PMC_40262634","title":"Custom CRISPR-Cas9 PAM variants via scalable engineering and machine learning.","date":"2025","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/40262634","citation_count":44,"is_preprint":false},{"pmid":"36484104","id":"PMC_36484104","title":"PAM-independent ultra-specific activation of CRISPR-Cas12a via sticky-end dsDNA.","date":"2022","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/36484104","citation_count":43,"is_preprint":false},{"pmid":"32070055","id":"PMC_32070055","title":"Simulated Microgravity Influences VEGF, MAPK, and PAM Signaling in Prostate Cancer Cells.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32070055","citation_count":41,"is_preprint":false},{"pmid":"29997255","id":"PMC_29997255","title":"PAM forms an atypical SCF ubiquitin ligase complex that ubiquitinates and degrades NMNAT2.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29997255","citation_count":41,"is_preprint":false},{"pmid":"32329776","id":"PMC_32329776","title":"Characterization of Cas12a nucleases reveals diverse PAM profiles between closely-related orthologs.","date":"2020","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/32329776","citation_count":40,"is_preprint":false},{"pmid":"38284432","id":"PMC_38284432","title":"PAM-Engineered Toehold Switches as Input-Responsive Activators of CRISPR-Cas12a for Sensing Applications.","date":"2024","source":"Angewandte Chemie (International ed. in English)","url":"https://pubmed.ncbi.nlm.nih.gov/38284432","citation_count":39,"is_preprint":false},{"pmid":"35552388","id":"PMC_35552388","title":"Genome editing in animals with minimal PAM CRISPR-Cas9 enzymes.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35552388","citation_count":38,"is_preprint":false},{"pmid":"30937444","id":"PMC_30937444","title":"Cas4-Cas1 fusions drive efficient PAM selection and control CRISPR adaptation.","date":"2019","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/30937444","citation_count":38,"is_preprint":false},{"pmid":"33547443","id":"PMC_33547443","title":"Scalable characterization of the PAM requirements of CRISPR-Cas enzymes using HT-PAMDA.","date":"2021","source":"Nature protocols","url":"https://pubmed.ncbi.nlm.nih.gov/33547443","citation_count":38,"is_preprint":false},{"pmid":"20573687","id":"PMC_20573687","title":"Signaling from the secretory granule to the nucleus: Uhmk1 and PAM.","date":"2010","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/20573687","citation_count":38,"is_preprint":false},{"pmid":"38551977","id":"PMC_38551977","title":"A PAM-Free One-Step Asymmetric RPA and CRISPR/Cas12b Combined Assay (OAR-CRISPR) for Rapid and Ultrasensitive DNA Detection.","date":"2024","source":"Analytical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/38551977","citation_count":37,"is_preprint":false},{"pmid":"10987251","id":"PMC_10987251","title":"Morphology and DNA content analysis in the evaluation of first trimester placentas for partial hydatidiform mole (PHM).","date":"2000","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/10987251","citation_count":37,"is_preprint":false},{"pmid":"31763447","id":"PMC_31763447","title":"The post-PAM interaction of RNA-guided spCas9 with DNA dictates its target binding and dissociation.","date":"2019","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/31763447","citation_count":34,"is_preprint":false},{"pmid":"31036811","id":"PMC_31036811","title":"Structural basis for the promiscuous PAM recognition by Corynebacterium diphtheriae Cas9.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31036811","citation_count":34,"is_preprint":false},{"pmid":"34593010","id":"PMC_34593010","title":"PAM-repeat associations and spacer selection preferences in single and co-occurring CRISPR-Cas systems.","date":"2021","source":"Genome biology","url":"https://pubmed.ncbi.nlm.nih.gov/34593010","citation_count":33,"is_preprint":false},{"pmid":"33420918","id":"PMC_33420918","title":"Efficient and high-fidelity base editor with expanded PAM compatibility for cytidine dinucleotide.","date":"2021","source":"Science China. Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33420918","citation_count":32,"is_preprint":false},{"pmid":"6548020","id":"PMC_6548020","title":"Production of VIP- and PHM (human PHI)-related peptides in human neuroblastoma cells.","date":"1984","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/6548020","citation_count":32,"is_preprint":false},{"pmid":"8037462","id":"PMC_8037462","title":"Purification and characterization of PAM-1, an integral membrane protein involved in peptide processing.","date":"1994","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/8037462","citation_count":32,"is_preprint":false},{"pmid":"37697004","id":"PMC_37697004","title":"Molecular basis and engineering of miniature Cas12f with C-rich PAM specificity.","date":"2023","source":"Nature chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/37697004","citation_count":31,"is_preprint":false},{"pmid":"36272409","id":"PMC_36272409","title":"DNA topology regulates PAM-Cas9 interaction and DNA unwinding to enable near-PAMless cleavage by thermophilic Cas9.","date":"2022","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/36272409","citation_count":30,"is_preprint":false},{"pmid":"38942756","id":"PMC_38942756","title":"PAM-flexible Engineered FnCas9 variants for robust and ultra-precise genome editing and diagnostics.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38942756","citation_count":29,"is_preprint":false},{"pmid":"35797934","id":"PMC_35797934","title":"PCDetection: PolyA-CRISPR/Cas12a-based miRNA detection without PAM restriction.","date":"2022","source":"Biosensors & bioelectronics","url":"https://pubmed.ncbi.nlm.nih.gov/35797934","citation_count":29,"is_preprint":false},{"pmid":"2839091","id":"PMC_2839091","title":"Complete nucleotide sequence of human vasoactive intestinal peptide/PHM-27 gene and its inducible promoter.","date":"1988","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/2839091","citation_count":29,"is_preprint":false},{"pmid":"34687846","id":"PMC_34687846","title":"Cas12a variants designed for lower genome-wide off-target effect through stringent PAM recognition.","date":"2021","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/34687846","citation_count":28,"is_preprint":false},{"pmid":"31709036","id":"PMC_31709036","title":"Efficient cleavage resolves PAM preferences of CRISPR-Cas in human cells.","date":"2019","source":"Cell regeneration (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/31709036","citation_count":28,"is_preprint":false},{"pmid":"34824292","id":"PMC_34824292","title":"Engineering a PAM-flexible SpdCas9 variant as a universal gene repressor.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34824292","citation_count":27,"is_preprint":false},{"pmid":"3840886","id":"PMC_3840886","title":"Evidence for common precursors but differential processing of VIP and PHM in VIP-producing tumors.","date":"1985","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/3840886","citation_count":26,"is_preprint":false},{"pmid":"17555844","id":"PMC_17555844","title":"Unconventional binding sites and receptors for VIP and related peptides PACAP and PHI/PHM: an update.","date":"2007","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/17555844","citation_count":24,"is_preprint":false},{"pmid":"28344037","id":"PMC_28344037","title":"Methods for decoding Cas9 protospacer adjacent motif (PAM) sequences: A brief overview.","date":"2017","source":"Methods (San Diego, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/28344037","citation_count":24,"is_preprint":false},{"pmid":"32494703","id":"PMC_32494703","title":"Programming PAM antennae for efficient CRISPR-Cas9 DNA editing.","date":"2020","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/32494703","citation_count":24,"is_preprint":false},{"pmid":"34874112","id":"PMC_34874112","title":"Compact SchCas9 Recognizes the Simple NNGR PAM.","date":"2021","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/34874112","citation_count":23,"is_preprint":false},{"pmid":"33441553","id":"PMC_33441553","title":"Engineered dual selection for directed evolution of SpCas9 PAM specificity.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33441553","citation_count":22,"is_preprint":false},{"pmid":"30894632","id":"PMC_30894632","title":"Construction of non-canonical PAM-targeting adenosine base editors by restriction enzyme-free DNA cloning using CRISPR-Cas9.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30894632","citation_count":21,"is_preprint":false},{"pmid":"31603896","id":"PMC_31603896","title":"Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease.","date":"2019","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/31603896","citation_count":21,"is_preprint":false},{"pmid":"12036515","id":"PMC_12036515","title":"Developmental expression of PAM (protein associated with MYC) in the rodent brain.","date":"2002","source":"Brain research. Developmental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/12036515","citation_count":21,"is_preprint":false},{"pmid":"28694521","id":"PMC_28694521","title":"Genome-wide analysis of long noncoding RNA profiling in PRRSV-infected PAM cells by RNA sequencing.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28694521","citation_count":21,"is_preprint":false},{"pmid":"35156077","id":"PMC_35156077","title":"Rapid detection of multiple SARS-CoV-2 variants of concern by PAM-targeting mutations.","date":"2022","source":"Cell reports methods","url":"https://pubmed.ncbi.nlm.nih.gov/35156077","citation_count":21,"is_preprint":false},{"pmid":"36272411","id":"PMC_36272411","title":"PAM binding ensures orientational integration during Cas4-Cas1-Cas2-mediated CRISPR adaptation.","date":"2022","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/36272411","citation_count":18,"is_preprint":false},{"pmid":"35666156","id":"PMC_35666156","title":"Molecular Mechanism of D1135E-Induced Discriminated CRISPR-Cas9 PAM Recognition.","date":"2022","source":"Journal of chemical information and modeling","url":"https://pubmed.ncbi.nlm.nih.gov/35666156","citation_count":18,"is_preprint":false},{"pmid":"35851988","id":"PMC_35851988","title":"seRNA PAM controls skeletal muscle satellite cell proliferation and aging through trans regulation of Timp2 expression synergistically with Ddx5.","date":"2022","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/35851988","citation_count":18,"is_preprint":false},{"pmid":"38010352","id":"PMC_38010352","title":"Completely Free from PAM Limitations: Asymmetric RPA with CRISPR/Cas12a for Nucleic Acid Assays.","date":"2023","source":"ACS sensors","url":"https://pubmed.ncbi.nlm.nih.gov/38010352","citation_count":18,"is_preprint":false},{"pmid":"36744495","id":"PMC_36744495","title":"Anti-CRISPR AcrIIC5 is a dsDNA mimic that inhibits type II-C Cas9 effectors by blocking PAM recognition.","date":"2023","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/36744495","citation_count":18,"is_preprint":false},{"pmid":"36774734","id":"PMC_36774734","title":"A universal and specific RNA biosensor via DNA circuit-mediated PAM-independent CRISPR/Cas12a and PolyA-rolling circle amplification.","date":"2023","source":"Biosensors & bioelectronics","url":"https://pubmed.ncbi.nlm.nih.gov/36774734","citation_count":17,"is_preprint":false},{"pmid":"37388215","id":"PMC_37388215","title":"Germline loss-of-function PAM variants are enriched in subjects with pituitary hypersecretion.","date":"2023","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/37388215","citation_count":17,"is_preprint":false},{"pmid":"33147965","id":"PMC_33147965","title":"Pam3CSK4-CDGSF Augments Antitumor Immunotherapy by Synergistically Activating TLR1/2 and STING.","date":"2020","source":"Bioconjugate chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33147965","citation_count":17,"is_preprint":false},{"pmid":"39294394","id":"PMC_39294394","title":"Bacteriophage λ exonuclease and a 5'-phosphorylated DNA guide allow PAM-independent targeting of double-stranded nucleic acids.","date":"2024","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/39294394","citation_count":17,"is_preprint":false},{"pmid":"37076593","id":"PMC_37076593","title":"PAM-flexible Cas9-mediated base editing of a hemophilia B mutation in induced pluripotent stem cells.","date":"2023","source":"Communications medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37076593","citation_count":17,"is_preprint":false},{"pmid":"8020060","id":"PMC_8020060","title":"Location of PHM/VIP mRNA in human gastrointestinal tract detected by in situ hybridization.","date":"1994","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/8020060","citation_count":17,"is_preprint":false},{"pmid":"18769030","id":"PMC_18769030","title":"The RCC1 domain of protein associated with Myc (PAM) interacts with and regulates KCC2.","date":"2008","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18769030","citation_count":16,"is_preprint":false},{"pmid":"39003282","id":"PMC_39003282","title":"TracrRNA reprogramming enables direct PAM-independent detection of RNA with diverse DNA-targeting Cas12 nucleases.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/39003282","citation_count":15,"is_preprint":false},{"pmid":"36378874","id":"PMC_36378874","title":"Expanding the Scope of Bacterial CRISPR Activation with PAM-Flexible dCas9 Variants.","date":"2022","source":"ACS synthetic biology","url":"https://pubmed.ncbi.nlm.nih.gov/36378874","citation_count":15,"is_preprint":false},{"pmid":"40151256","id":"PMC_40151256","title":"PAM-Independent CRISPR-Cas12a System for Specific Assays of Single Nucleotide Variants.","date":"2025","source":"JACS Au","url":"https://pubmed.ncbi.nlm.nih.gov/40151256","citation_count":15,"is_preprint":false},{"pmid":"36134715","id":"PMC_36134715","title":"CRISPRactivation-SMS, a message for PAM sequence independent gene up-regulation in Escherichia coli.","date":"2022","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/36134715","citation_count":14,"is_preprint":false},{"pmid":"37159673","id":"PMC_37159673","title":"A Cas12a ortholog with distinct TTNA PAM enables sensitive detection of HPV16/18.","date":"2023","source":"Cell reports methods","url":"https://pubmed.ncbi.nlm.nih.gov/37159673","citation_count":14,"is_preprint":false},{"pmid":"33472174","id":"PMC_33472174","title":"PAM (PIK3/AKT/mTOR) signaling in glia: potential contributions to brain tumors in aging.","date":"2021","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/33472174","citation_count":14,"is_preprint":false},{"pmid":"34850124","id":"PMC_34850124","title":"Efficient DNA interrogation of SpCas9 governed by its electrostatic interaction with DNA beyond the PAM and protospacer.","date":"2021","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/34850124","citation_count":13,"is_preprint":false},{"pmid":"31984442","id":"PMC_31984442","title":"PAM haploinsufficiency does not accelerate the development of diet- and human IAPP-induced diabetes in mice.","date":"2020","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/31984442","citation_count":13,"is_preprint":false},{"pmid":"34089560","id":"PMC_34089560","title":"PAM: diverse roles in neuroendocrine cells, cardiomyocytes, and green algae.","date":"2021","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/34089560","citation_count":12,"is_preprint":false},{"pmid":"35453677","id":"PMC_35453677","title":"Cell Type-Specific Anti-Adhesion Properties of Peritoneal Cell Treatment with Plasma-Activated Media (PAM).","date":"2022","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/35453677","citation_count":12,"is_preprint":false},{"pmid":"20488212","id":"PMC_20488212","title":"A PAL for Schistosoma mansoni PHM.","date":"2010","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/20488212","citation_count":12,"is_preprint":false},{"pmid":"34513298","id":"PMC_34513298","title":"CABE-RY: A PAM-flexible dual-mutation base editor for reliable modeling of multi-nucleotide variants.","date":"2021","source":"Molecular therapy. Nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/34513298","citation_count":12,"is_preprint":false},{"pmid":"36119590","id":"PMC_36119590","title":"Abscisic acid-polyacrylamide (ABA-PAM) treatment enhances forage grass growth and soil microbial diversity under drought stress.","date":"2022","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/36119590","citation_count":12,"is_preprint":false},{"pmid":"29375690","id":"PMC_29375690","title":"Effect of SLC34A2 gene mutation on extracellular phosphorus transport in PAM alveolar epithelial cells.","date":"2017","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29375690","citation_count":11,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":44742,"output_tokens":6078,"usd":0.112698,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":13595,"output_tokens":4203,"usd":0.086525,"stage2_stop_reason":"end_turn"},"total_usd":0.199223,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"Looking at the corpus, I need to identify papers about the canonical human PAM gene (Peptidylglycine α-Amidating Monooxygenase), also known by its alias PHM (peptidylglycine α-hydroxylating monooxygenase). The vast majority of papers in this corpus are about CRISPR PAM (protospacer adjacent motif) sequences, which are NOT the human PAM gene. I will filter carefully.\n\nRelevant papers about the canonical PAM/PHM gene:\n- PMID:26667899 (PAM enzyme, amidation, copper, ascorbate)\n- PMID:10993678 (PHM in Drosophila - ortholog)\n- PMID:20534529 (Pam E3 ligase for Rev-erb alpha)\n- PMID:14559897 (Pam interacts with TSC1/TSC2)\n- PMID:18308511 (Pam as E3 ligase for tuberin/TSC)\n- PMID:29997255 (PAM/MYCBP2 SCF ubiquitin ligase, NMNAT2)\n- PMID:15257286 (PAM inhibits adenylyl cyclase, S1P signaling)\n- PMID:20573687 (PAM signaling from secretory granule to nucleus)\n- PMID:17967878 (DIMM activates PHM in Drosophila)\n- PMID:18769030 (PAM RCC1 domain interacts with KCC2)\n- PMID:8037462 (PAM-1 purification, integral membrane protein)\n- PMID:37388215 (PAM loss-of-function in pituitary)\n- PMID:34089560 (PAM diverse roles review with mechanistic content)\n- PMID:20488212 (Schistosoma PHM/PAL - ortholog amidating enzyme)\n- PMID:2987932 (VIP/PHM-27 gene structure)\n- PMID:2839091 (VIP/PHM-27 gene sequence)\n- PMID:6548020 (VIP/PHM production in neuroblastoma)\n- PMID:3840886 (VIP/PHM processing in tumors)\n- PMID:2318966 (PAM 212 keratinocyte cell line - NOT the PAM gene)\n- PMID:12036515 (PAM/Myc-associated protein brain expression)\n- PMID:8020060 (PHM/VIP mRNA localization)\n- PMID:3018707 (VIP/PHM receptors)\n- PMID:2422707 (VIP/PHM effects on gland)\n- PMID:31984442 (PAM haploinsufficiency in mice)\n- PMID:10987251 (PHM = partial hydatidiform mole - NOT the gene)\n- PMID:77 (seRNA PAM lncRNA - NOT the canonical protein)\n- PMID:40 (PAM = PI3K/AKT/mTOR pathway - NOT the gene)\n- PMID:96 (PAM = plasma-activated media - NOT the gene)\n- PMID:99 (ABA-PAM = polyacrylamide - NOT the gene)\n- PMID:100 (PAM = pulmonary alveolar microlithiasis - NOT the gene)\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2015,\n      \"finding\": \"PAM (peptidylglycine α-amidating monooxygenase) catalyzes C-terminal amidation of peptidylglycine substrates in two sequential steps: the PHM (peptidylglycine α-hydroxylating monooxygenase) domain catalyzes copper- and ascorbate-dependent α-hydroxylation, and the PAL (peptidyl-α-hydroxyglycine α-amidating lyase) domain cleaves the N-C bond to produce amidated peptide and glyoxylate. Both catalytic cores are contained within the luminal domain of PAM, a type 1 integral membrane protein, and crystal structures of both catalytic cores have been determined revealing interactions with metals, molecular oxygen, and substrate.\",\n      \"method\": \"Biochemical purification, enzymatic assay, structural determination (crystallography), cloning\",\n      \"journal\": \"Journal of molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structures of both catalytic cores determined, in vitro enzymatic assays, replicated across multiple labs over decades\",\n      \"pmids\": [\"26667899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"In Drosophila, PHM (the ortholog of human PAM's PHM domain) is the rate-limiting enzyme for C-terminal α-amidation of secretory peptides. PHM null mutants lack PHM protein and enzyme activity, die as late embryos or young larvae, and show near-complete absence of amidated peptides while peptide precursors, non-amidated neuropeptides, and other biosynthetic enzymes remain detectable. PHM is required throughout the life of Drosophila for peptide amidating activity.\",\n      \"method\": \"Genetic loss-of-function (null mutants, hypomorphs), transgenic rescue, enzymatic activity assay, immunodetection of neuropeptides\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple alleles, rescue experiments, direct biochemical validation of enzyme activity loss and substrate accumulation\",\n      \"pmids\": [\"10993678\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"PAM-1, a type I integral membrane protein, was purified to homogeneity from stably transfected HEK-293 cell membranes. Purified PAM-1 exhibits an acidic pH optimum and lower maximal velocity than soluble bifunctional PAM. Limited tryptic digestion of PAM-1 releases monofunctional PHM (peptidylglycine α-hydroxylating monooxygenase), increasing its specific activity ~fourfold and shifting its pH optimum to match that of PAL (peptidyl-α-hydroxyglycine α-amidating lyase).\",\n      \"method\": \"Affinity chromatography purification, enzymatic activity assay (in vitro), limited proteolysis\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro biochemical reconstitution with purified protein and defined enzymatic assays in a single rigorous study\",\n      \"pmids\": [\"8037462\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PAM (also called Myc-bp2/MYCBP2) and Arf-bp1 are E3 ubiquitin ligases that co-purify with the circadian heme receptor Rev-erb alpha and are required for its ubiquitination. RNA interference-mediated depletion of Arf-bp1 and Pam stabilizes Rev-erb alpha protein and protects it from degradation triggered by lithium or serum shock, thereby modulating Clock gene expression and circadian function in mouse hepatoma cells.\",\n      \"method\": \"Co-purification (biochemical), RNA interference (RNAi) knockdown, ubiquitination assay, protein stability assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-purification plus functional RNAi with defined molecular phenotype (ubiquitination and protein stability), two orthogonal methods\",\n      \"pmids\": [\"20534529\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Pam (Protein associated with Myc/MYCBP2) physically associates with the tuberin-hamartin (TSC2-TSC1) complex in the brain. The C-terminal RING zinc finger domain of Pam binds to tuberin. Pam co-localizes with tuberin and hamartin in neurites and growth cones of cortical neurons. Genetic studies in Drosophila showed that Highwire (the Pam ortholog) can genetically interact with the Tsc1·Tsc2 complex and negatively regulate its activity.\",\n      \"method\": \"Co-immunoprecipitation, yeast two-hybrid, co-localization (immunofluorescence), Drosophila genetic epistasis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP and domain mapping plus genetic epistasis in Drosophila, but mechanistic detail on ubiquitination not yet shown in this paper\",\n      \"pmids\": [\"14559897\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Pam (MYCBP2) functions as an E3 ubiquitin ligase: it associates with E2 ubiquitin-conjugating enzymes and ubiquitinates tuberin (TSC2) through its RING finger domain in mammalian cells. Tuberin ubiquitination by Pam is independent of its phosphorylation by Akt, RSK1, or ERK. Pam also self-ubiquitinates via its RING finger domain. The TSC1 protein hamartin protects tuberin from Pam-mediated ubiquitination, but fails to protect a disease-associated TSC2 missense mutant. Pam knockdown by RNAi in rat primary neurons elevates tuberin levels and inhibits mTOR signaling.\",\n      \"method\": \"In vitro ubiquitination assay, co-immunoprecipitation, RNAi knockdown, mTOR pathway readout, domain mutagenesis (RING finger)\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro ubiquitination assay with domain mutagenesis, RNAi with defined pathway phenotype, and Co-IP; multiple orthogonal methods in one study\",\n      \"pmids\": [\"18308511\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Human PAM (MYCBP2) forms a noncanonical SCF-like ubiquitin ligase complex containing FBXO45 and SKP1 but lacking CUL1. FBXO45 is important for assembly of the PAM/FBXO45/SKP1 complex rather than solely for substrate recognition. SKP1 acts as an auxiliary component of the target recognition module, enhancing FBXO45 binding to NMNAT2. PAM polyubiquitinates NMNAT2 and regulates NMNAT2 protein stability and degradation by the proteasome.\",\n      \"method\": \"Co-immunoprecipitation, biochemical reconstitution of complex, in vitro ubiquitination assay, proteasome degradation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — biochemical reconstitution of SCF-like complex, in vitro ubiquitination assay, protein stability assay; multiple orthogonal methods\",\n      \"pmids\": [\"29997255\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"PAM (Protein Associated with Myc/MYCBP2) is one of the most potent inhibitors of adenylyl cyclase activity. PAM localizes at the endoplasmic reticulum in HeLa cells and is recruited to the plasma membrane upon treatment with sphingosine-1-phosphate (S1P), causing inhibition of adenylyl cyclase activity. S1P-induced late-phase adenylyl cyclase inhibition (20–240 min) is PAM-dependent, whereas the initial phase (1–10 min) is Gi-mediated and PAM-independent. This makes PAM the longest-lasting nontranscriptional regulator of adenylyl cyclase activity known.\",\n      \"method\": \"Subcellular fractionation/localization, purification of S1P as serum factor, adenylyl cyclase activity assay, PAM knockdown\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization with functional consequence, biochemical activity assay, identification of upstream activating signal, and functional knockdown; multiple orthogonal methods\",\n      \"pmids\": [\"15257286\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The cytosolic domain (CD) of PAM (peptidylglycine α-amidating monooxygenase) is basally phosphorylated by Uhmk1 (U2AF homology motif kinase 1) and other Ser/Thr kinases. Endoproteolytic cleavage of PAM releases a soluble CD fragment that localizes to the nucleus. Nuclear localization of PAM-CD is decreased by phosphomimetic mutations in PAM-CD or by overexpression of active Uhmk1. PAM-CD can increase expression of a subset of genes including aquaporin 1 (Aqp1) in AtT-20 cells, and this relationship was confirmed in vivo in Pam heterozygous mice.\",\n      \"method\": \"Kinase assay (phosphorylation), subcellular fractionation/localization, microarray gene expression, transgenic mouse (Pam+/- vs Pam+/+), phosphomimetic mutagenesis\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (kinase assay, localization, mutagenesis, microarray, in vivo mouse model) establishing a secretory granule-to-nucleus signaling pathway\",\n      \"pmids\": [\"20573687\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The basic helix-loop-helix protein DIMMED (DIMM) directly activates transcription of the PHM gene (Drosophila ortholog of human PAM) in peptidergic neurons. DIMM activity requires its basic region and three E-box sites within PHM's first intron. All three E-boxes contribute to transcriptional activation and interact cooperatively. The mammalian DIMM ortholog MIST1 also transactivates the PHM gene. In vivo PHM regulatory region expression requires dimm function.\",\n      \"method\": \"Transfection/reporter assay in HEK293 cells, site-directed mutagenesis of E-box sites, in vivo Drosophila genetics (dimm mutants), ChIP-equivalent reporter analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — direct transcription factor binding and mutagenesis of target sites combined with in vivo genetic validation\",\n      \"pmids\": [\"17967878\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The RCC1 (Regulator of Chromatin Condensation) domain of PAM (Protein Associated with Myc) binds to the carboxyl terminus of the neuronal KCC2 potassium-chloride cotransporter. This interaction was identified by yeast two-hybrid, confirmed by GST pull-down, and co-immunoprecipitation after co-expression in HEK293 cells. Functional 86Rb/K+ uptake assays showed that RCC1/PAM causes increased KCC2-mediated ion flux. A point mutation in the 20-amino-acid KCC2 binding region abolishes both the RCC1/PAM interaction and N-ethylmaleimide activation of KCC2.\",\n      \"method\": \"Yeast two-hybrid, GST pull-down, co-immunoprecipitation, ion flux assay (86Rb uptake), site-directed mutagenesis\",\n      \"journal\": \"Cellular physiology and biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal binding assays (Y2H, GST pulldown, Co-IP) plus functional ion flux assay and domain mutagenesis linking interaction to function\",\n      \"pmids\": [\"18769030\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PAM (peptidylglycine α-amidating monooxygenase) is essential; mice lacking PAM survive only until mid-gestation. PAM is present in cilia of Chlamydomonas reinhardtii (a unicellular eukaryote lacking secretory granules), suggesting PAM-like enzyme was present in the last eukaryotic common ancestor. Despite similar catalytic features between human and C. reinhardtii PAM, trafficking of PAM differs between species. The intrinsically disordered cytosolic domain of PAM is not essential for catalytic activity but is essential for PAM trafficking.\",\n      \"method\": \"Genetic knockout (mouse), phylogenetic analysis, biochemical characterization, cell biological localization studies\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — review synthesizing multiple prior experiments including mouse knockout lethality and localization studies; no single new experiment but synthesizes established mechanistic findings\",\n      \"pmids\": [\"34089560\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Germline loss-of-function variants in the PAM gene (encoding peptidylglycine α-amidating monooxygenase) are enriched in subjects with pituitary hypersecretion. Functional testing of identified PAM variants in vitro demonstrated deleterious effects on protein expression, protein trafficking (Western blotting), mRNA splicing (minigene assays), and amidation activity (cell lysate and serum amidation assays), confirming that reduced PAM function is associated with pituitary adenoma and hypersecretion.\",\n      \"method\": \"Germline sequencing, Western blotting, minigene splicing assay, enzymatic amidation activity assay in cell lysates and serum\",\n      \"journal\": \"Frontiers in endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — functional in vitro validation of multiple variants by distinct methods (expression, trafficking, splicing, enzymatic activity), single lab\",\n      \"pmids\": [\"37388215\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"PAM (Protein Associated with Myc/MYCBP2) mRNA is highly expressed in specific brain regions including hippocampus, dentate gyrus, and cerebellum, restricted to pyramidal cells of hippocampus and granule cells of dentate gyrus and cerebellum. PAM mRNA expression is developmentally regulated: it is turned on after birth and upregulated during the first postnatal two weeks, then remains elevated into adulthood. No alterations in PAM mRNA expression are detected in mice deficient in adenylyl cyclase isoforms I or VIII.\",\n      \"method\": \"In situ hybridization, developmental time course analysis, adenylyl cyclase knockout mouse analysis\",\n      \"journal\": \"Brain research. Developmental brain research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — localization by in situ hybridization without direct functional consequence established; negative result regarding adenylyl cyclase isoform regulation\",\n      \"pmids\": [\"12036515\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1985,\n      \"finding\": \"The human precursor gene for VIP and PHM-27 was characterized: PHM-27 (the human ortholog of PHI, with N-terminal histidine and C-terminal methionine amide) and VIP are encoded on two separate, adjacent exons separated by a 0.75-kb intron. Each exon encodes both the hormone amino acid residues and post-translational processing signal sequences. The 3' splice sites of the two exons contain an identical stretch of nine nucleotides, suggesting possible alternative RNA processing.\",\n      \"method\": \"Oligodeoxynucleotide probe hybridization, direct DNA sequencing, gene structure analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct sequencing establishing gene structure with distinct exons for PHM-27 and VIP; foundational structural finding\",\n      \"pmids\": [\"2987932\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"The complete human VIP/PHM-27 gene spans 8,837 bp and consists of seven exons and six introns. PHM-27 is encoded by exon IV and VIP by exon V. The VIP- and PHM-27-encoding exons are homologous, suggesting duplication from an ancestral exon. The functional promoter (28 bp upstream of the cap site) is inducible by cAMP and phorbol esters in human neuroblastoma cells.\",\n      \"method\": \"DNA sequencing, primer extension, exon mapping, mung bean nuclease mapping, promoter-reporter assay\",\n      \"journal\": \"Annals of the New York Academy of Sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — complete gene sequencing combined with functional promoter mapping by multiple methods\",\n      \"pmids\": [\"2839091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In Schistosoma mansoni, a monofunctional PAL (SmPAL) enzyme was identified that has functionally similar catalytic activity to the PAL domain of human bifunctional PAM but shows key catalytic core amino acid substitutions. SmPAL mRNA is expressed in neuronal cell bodies of the central nervous system of adult schistosomes, consistent with its role in amidating neuropeptides for neuromuscular function.\",\n      \"method\": \"Heterologous expression and enzymatic characterization, in situ hybridization, RNAi (knockdown attempted with variable success)\",\n      \"journal\": \"Molecular and biochemical parasitology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — ortholog characterization in a parasitic organism; mechanistic findings indirect to human PAM; single lab, single main method for functional characterization\",\n      \"pmids\": [\"20488212\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PAM (peptidylglycine α-amidating monooxygenase/MYCBP2) is a multifunctional type I integral membrane protein: its luminal domain contains two catalytic cores (PHM and PAL) that sequentially catalyze copper- and ascorbate-dependent C-terminal α-amidation of peptidylglycine substrates; its intrinsically disordered cytosolic domain, phosphorylated by Uhmk1, is essential for trafficking and mediates retrograde signaling from secretory granules to the nucleus to regulate gene expression; and separately, its RING finger-containing form (MYCBP2/PAM) functions as an E3 ubiquitin ligase within a noncanonical SCF complex (with FBXO45 and SKP1 but lacking CUL1) to ubiquitinate substrates including TSC2/tuberin and NMNAT2, thereby regulating mTOR signaling, axonal degeneration, and circadian rhythm (via Rev-erb alpha degradation), while its RCC1 domain interacts with and activates the KCC2 potassium-chloride cotransporter.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PAM is a multifunctional protein whose name reflects two distinct biochemical identities captured in this corpus. As peptidylglycine α-amidating monooxygenase, it is a type I integral membrane enzyme whose luminal domain houses two sequential catalytic cores—PHM, which performs copper- and ascorbate-dependent α-hydroxylation, and PAL, which cleaves the resulting peptidyl-α-hydroxyglycine to yield C-terminally amidated peptide and glyoxylate [#0, #2]. This bifunctional amidation is the rate-limiting step in producing mature bioactive secretory peptides, demonstrated by loss-of-function studies in Drosophila where PHM nulls fail to amidate neuropeptides and die during development [#1]. The enzyme's intrinsically disordered cytosolic domain is dispensable for catalysis but essential for trafficking; it is phosphorylated by Uhmk1, and a cleaved soluble cytosolic fragment translocates to the nucleus to regulate expression of genes such as Aqp1, constituting a secretory-granule-to-nucleus signaling route [#8, #11]. PAM is essential in mouse (knockout lethal at mid-gestation), and germline loss-of-function variants that impair its expression, trafficking, splicing, and amidation activity are associated with pituitary hypersecretion and adenoma [#11, #12]. Separately, the same locus (also called MYCBP2/Pam) encodes a RING-finger E3 ubiquitin ligase that assembles a noncanonical SCF-like complex with FBXO45 and SKP1 but lacking CUL1; this complex polyubiquitinates substrates including TSC2/tuberin—thereby modulating mTOR signaling—and NMNAT2, controlling its proteasomal stability [#5, #6], and also targets the circadian receptor Rev-erbα for degradation to influence Clock gene expression [#3]. Additional regulatory activities include potent, S1P-induced long-lasting inhibition of adenylyl cyclase [#7] and an RCC1 domain that binds and activates the neuronal KCC2 potassium-chloride cotransporter [#10].\",\n  \"teleology\": [\n    {\n      \"year\": 1985,\n      \"claim\": \"Establishing the genomic architecture of the amidated-peptide system showed that hormone-coding exons carry their own post-translational processing signals, framing amidation as a programmed maturation step.\",\n      \"evidence\": \"DNA sequencing and gene structure analysis of the human VIP/PHM-27 precursor gene\",\n      \"pmids\": [\"2987932\", \"2839091\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not characterize the amidating enzyme itself\", \"Promoter regulation studied only in neuroblastoma cells\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Purification of the membrane enzyme to homogeneity defined PAM as a bifunctional type I integral membrane protein whose two catalytic activities can be physically separated, answering how a single protein performs two sequential reactions.\",\n      \"evidence\": \"Affinity purification from transfected HEK-293 membranes, in vitro enzymatic assays, limited proteolysis releasing monofunctional PHM\",\n      \"pmids\": [\"8037462\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-resolution catalytic mechanism not yet resolved\", \"Physiological role of membrane vs soluble forms unclear\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Genetic ablation in Drosophila established PHM/PAM as the rate-limiting and essential enzyme for peptide amidation in vivo, showing amidation is required for organismal viability.\",\n      \"evidence\": \"Null and hypomorph alleles, transgenic rescue, enzyme activity assay, neuropeptide immunodetection\",\n      \"pmids\": [\"10993678\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific amidated peptides essential for survival not pinpointed\", \"Mammalian requirement not addressed here\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identification of PAM/MYCBP2 binding to the TSC1-TSC2 complex via its RING domain connected the locus to mTOR-pathway regulation and growth-cone biology.\",\n      \"evidence\": \"Co-IP, yeast two-hybrid, neuronal co-localization, Drosophila genetic epistasis with Tsc1/Tsc2\",\n      \"pmids\": [\"14559897\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Ubiquitination of tuberin not demonstrated in this study\", \"Direct enzymatic activity inferred not shown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Discovery that PAM is an S1P-recruited, long-lasting inhibitor of adenylyl cyclase added a membrane-signaling function distinct from amidation.\",\n      \"evidence\": \"Subcellular localization, S1P identification as serum factor, adenylyl cyclase activity assay, PAM knockdown\",\n      \"pmids\": [\"15257286\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism of cyclase inhibition unresolved\", \"Which PAM form/domain mediates this is unclear\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Demonstration that PAM functions as a bona fide RING E3 ligase that ubiquitinates tuberin and self-ubiquitinates, with TSC1 protection, defined its mechanism of mTOR regulation.\",\n      \"evidence\": \"In vitro ubiquitination with RING mutagenesis, Co-IP, neuronal RNAi with mTOR readout\",\n      \"pmids\": [\"18308511\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E2 partner identity not fully defined\", \"Ubiquitin chain topology not characterized\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Mapping the RCC1 domain interaction with KCC2 revealed a non-catalytic role in activating neuronal chloride transport.\",\n      \"evidence\": \"Yeast two-hybrid, GST pull-down, Co-IP, 86Rb ion flux assay, point mutagenesis of binding region\",\n      \"pmids\": [\"18769030\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which RCC1 binding activates transport unknown\", \"In vivo relevance to neuronal chloride homeostasis untested here\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Linking PAM/MYCBP2 to Rev-erbα ubiquitination extended its E3 ligase role into circadian regulation.\",\n      \"evidence\": \"Co-purification, RNAi stabilization of Rev-erbα, ubiquitination and protein stability assays in mouse hepatoma cells\",\n      \"pmids\": [\"20534529\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect ubiquitination of Rev-erbα not fully separated from Arf-bp1 contribution\", \"Complex composition for this substrate undefined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identification of Uhmk1 phosphorylation of the cytosolic domain and nuclear translocation of a cleaved CD fragment established a secretory-granule-to-nucleus retrograde signaling pathway controlling gene expression.\",\n      \"evidence\": \"Kinase assay, subcellular fractionation, phosphomimetic mutagenesis, microarray, Pam+/- mouse validation\",\n      \"pmids\": [\"20573687\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Protease that generates the CD fragment not identified\", \"Direct DNA/transcription-factor targets of CD unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Reconstitution of a noncanonical CUL1-lacking SCF-like complex (PAM/FBXO45/SKP1) targeting NMNAT2 defined the molecular architecture of PAM's ligase module and its role in NMNAT2 turnover.\",\n      \"evidence\": \"Co-IP, biochemical complex reconstitution, in vitro ubiquitination, proteasome degradation assay\",\n      \"pmids\": [\"29997255\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How substrate selection switches between TSC2, NMNAT2, and Rev-erbα is unresolved\", \"Structural model of the assembled complex absent\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Mouse knockout lethality plus conservation in a ciliated unicellular eukaryote established PAM as an ancient, essential enzyme and assigned the cytosolic domain a trafficking-specific, catalysis-independent role.\",\n      \"evidence\": \"Mouse knockout, phylogenetic analysis, Chlamydomonas localization, domain characterization (review synthesis)\",\n      \"pmids\": [\"34089560\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Species differences in trafficking mechanism unexplained\", \"Cause of mid-gestation lethality not defined molecularly\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Functional testing of germline loss-of-function variants tied reduced PAM amidation function to human pituitary hypersecretion and adenoma, providing a disease link.\",\n      \"evidence\": \"Germline sequencing with in vitro expression, trafficking, minigene splicing, and amidation activity assays\",\n      \"pmids\": [\"37388215\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab functional validation\", \"Mechanism connecting reduced amidation to hypersecretion not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the dual identities—amidating enzyme versus RING E3 ligase—relate at the level of gene products, and how the ligase selects among its diverse substrates, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of the substrate-recognition switch\", \"Relationship between the amidation and ubiquitination functions of the locus unclear in the corpus\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0016874\", \"supporting_discovery_ids\": [5, 6, 3]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [5, 6]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [7, 10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2, 7]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"GO:0005929\", \"supporting_discovery_ids\": [11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [5, 7]},\n      {\"term_id\": \"R-HSA-9909396\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"complexes\": [\n      \"noncanonical SCF-like complex (PAM/FBXO45/SKP1, lacking CUL1)\"\n    ],\n    \"partners\": [\n      \"FBXO45\",\n      \"SKP1\",\n      \"TSC2\",\n      \"TSC1\",\n      \"NMNAT2\",\n      \"Rev-erbα\",\n      \"Uhmk1\",\n      \"KCC2\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}